en
Scientific article
Open access
English

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

Published inClinical infectious diseases, vol. 54 Suppl 4, p. S245-249
Publication date2012
Abstract

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

Keywords
  • Anti-Retroviral Agents/pharmacology
  • Developing Countries
  • Drug Resistance, Viral
  • HIV Infections/drug therapy
  • Health Policy
  • Health Surveys
  • Humans
  • World Health
  • World Health Organization
Research group
Citation (ISO format)
JORDAN, M R et al. Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. In: Clinical infectious diseases, 2012, vol. 54 Suppl 4, p. S245–249. doi: 10.1093/cid/cis206
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1058-4838
549views
521downloads

Technical informations

Creation12/03/2013 2:12:00 PM
First validation12/03/2013 2:12:00 PM
Update time03/14/2023 8:40:30 PM
Status update03/14/2023 8:40:29 PM
Last indexation01/16/2024 8:21:22 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack